Zenabis Global Inc. Announces Results of Annual General and Special Meeting

VANCOUVERJune 26, 2019  – Zenabis Global Inc. (TSX: ZENA(“Zenabis” or the “Company“)  announces the results of matters voted on at the annual general and special meeting of shareholders of the Company held in Langley, British Columbia on June 25, 2019.  

The number of directors of the Company were fixed at seven (7). Detailed results of the vote are as follows:

Votes For

% For

Votes Against

% Against

105,193,641

99.91%

92,601

0.09%

The nominees listed in its management information circular dated May 20, 2019 (the “Information Circular“) were elected as directors of Zenabis. Detailed results of the vote for the election of directors are set out below:

 Name of Nominee

Votes For

% Votes For

Votes Withheld

% Votes Withheld

Leo Benne

105,030,121

99.76%

256,121

0.24%

Daniel Burns

93,266,721

88.58%

12,019,521

11.42%

Andrew Grieve

85,086,906

80.81%

20,199,336

19.19%

Natascha Kiernan

105,014,302

99.74%

271,940

0.26%

Manoj (Monty) Sikka

105,020,037

99.75%

266,205

0.25%

Adam Spears

104,987,102

99.72%

299,140

0.28%

Larry Van Wieren

93,271,121

88.59%

12,015,121

11.41%

KPMG LLP were re-appointed as auditor of the Company until the next annual general meeting of shareholders of the Company. Detailed results of the vote are as follows:

Votes For

% For

Votes Withheld

% Votes Withheld

105,881,635

99.87%

141,805

0.13%

Approval of the Amendment of the Company’s Stock Option Plan such that it is replaced in its entirety with an Omnibus Incentive Plan was confirmed and approved by the shareholders of the Company. Detailed results of the vote are as follows:

Votes For

% For

Votes Against

% Against

93,135,996

88.46%

12,150,246

11.54%

Approval of the Amendment of the Articles such that they are replaced in their entirety with the form attached to the Company’s Information Circular was confirmed and approved by the shareholders of the Company. Detailed results of the vote are as follows:

Votes For

% For

Votes Against

% Against

93,150,891

88.47%

12,135,351

11.53%

About Zenabis

Zenabis is a significant Canadian licensed cannabis cultivator of medical and recreational cannabis, and a propagator and cultivator of floral and vegetable products. Zenabis employs staff coast-to-coast, across facilities in Atholville, New BrunswickDeltaAldergrovePitt Meadows and Langley, British Columbia; and Stellarton, Nova Scotia. In addition to gaining technologically advanced knowledge of plant propagation, the recent addition of state-of-the-art greenhouses in LangleyPitt Meadows and Aldergrove provides Zenabis with 3.5 million square feet of facility space that can, if fully converted, be dedicated to cannabis production.

If all facility space at Zenabis Atholville, Zenabis Stellarton, Zenabis Delta and Zenabis Langley is fully converted and dedicated to production, Zenabis will own, and have access to 660,000 square feet of high quality indoor cannabis production space, as well as 2.1 million square feet of greenhouse cannabis production space at its Langley facility, with this production strategically positioned on Canada’s coasts. Zenabis expects these facilities to have an annual design capacity of 131,300 kg of dried cannabis by the third quarter of 2019. These facilities, if fully built out and converted for cannabis production, would have an annual design capacity to yield approximately 479,300 kg of dried cannabis annually, for both national and international market distribution. An additional 700,000 square feet of greenhouse space will be used to continue the existing propagation business and produce industrial hemp, and can be converted to cannabis production at such a time that is beneficial to the strategic position of the Company. The Zenabis brand name is used in the cannabis medical market, while the Namaste and Blazery brand names are used in the cannabis adult-use recreational market, and the True Büch brand name is used for Zenabis’ kombucha products.

SOURCE Zenabis Global Inc.

For further information: Media Relations: media@zenabis.com, 1 (844) 523-8679; Investor Relations: invest@zenabis.com, 1 (844) 523-8679

Related Links

www.zenabis.com

Leave a Reply

avatar
  Subscribe  
Notify of